Some Thoughts on the Use of Predictive Probability in Clinical Trials von Li, Heng, Buzoianu, Manuela, Chakraborty, Adrijo, Dong, Li Ming, Ko, Chia-Wen, Li, Xuefeng, Lu, Nelson, Qu, Yanping, Xu, Yunling, Yan, Xu

Volltext

HLA‐Specific Antibodies are Risk Factors for Lymphocytic Bronchiolitis and Chronic Lung Allograft Dysfunction von Girnita, Alin L., Duquesnoy, Rene, Yousem, Samuel A., Iacono, Aldo T., Corcoran, Timothy E., Buzoianu, Manuela, Johnson, Bruce, Spichty, Kathy J., Dauber, James H., Burckart, Gilbert, Griffith, Bartley P., McCurry, Kenneth R., Zeevi, Adriana

Volltext

Circulating tumor cells: application as a biomarker for molecular characterization and predictor of survival in an all-comer solid tumor phase I clinical study von Bao, Haifeng, Burke, Patricia A, Huang, Jiaqi, Chen, Xiaoru, Brohawn, Philip Z, Yao, Yihong, Lechleider, Robert J, Sikorski, Robert S, Buzoianu, Manuela, Zhang, Jianliang, Shi, Xiaoqing, Richman, Laura K, Lavallee, Theresa M

Volltext

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin alpha(v)beta(3), + or - dacarbazine in patients with stage IV metastatic melanoma von Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M

Volltext

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin αvβ3, ± dacarbazine in patients with stage IV metastatic melanoma von Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M.

Volltext

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumors von Annunziata, Christina M., Kohn, Elise C., LoRusso, Patricia, Houston, Nicole D., Coleman, Robert L., Buzoianu, Manuela, Robbie, Gabriel, Lechleider, Robert

Volltext

Sex-specific Long-term Outcomes of Watchman Left Atrial Appendage Closure for Stroke Prevention in Atrial Fibrillation von Jiang, Hongying, Zheng, Qi, Cheng, Yun-Ju, Buzoianu, Manuela, Neubrander, Rachel, Zusterzeel, Robbert, Farb, Andrew, Moscucci, Mauro

Volltext

Evaluation of relationship between progression-free survival and overall survival in first-line treatment of advanced non-small cell lung cancer von Buzoianu, Manuela, Hong, Dr Shengyan, Shi, Li, Viner, Jaye

Volltext

Adjusting for verification bias in diagnostic test evaluation: A Bayesian approach von Buzoianu, Manuela, Kadane, Joseph B.

Volltext

Optimal Bayesian Design for Patient Selection in a Clinical Study von Buzoianu, Manuela, Kadane, Joseph B.

Volltext

A Novel Anti-CD22 Immunotoxin, Moxetumomab Pasudotox: Phase I Study in Pediatric Acute Lymphoblastic Leukemia (ALL) von Wayne, Alan S, Bhojwani, Deepa, Silverman, Lewis B., Richards, Kelly, Stetler-Stevenson, Maryalice, Shah, Nirali N, Jeha, Sima, Pui, Ching-Hon, Buzoianu, Manuela, FitzGerald, David J., Kreitman, Robert J., Ibrahim, Ramy, Pastan, Ira

Volltext

A Phase 1 Study of Moxetumomab Pasudotox, An Anti-CD22 Recombinant Immunotoxin, In Relapsed/Refractory Hairy Cell Leukemia (HCL): Updated Results von Kreitman, Robert J., Tallman, Martin S., Coutre, Steven, Robak, Tadeusz, Wilson, Wyndham H., Stetler-Stevenson, Maryalice, Noel, Pierre, FitzGerald, David J., Buzoianu, Manuela, Lechleider, Robert J., Pastan, Ira

Volltext

Pharmacodynamic (Phase 0) Study Using Etaracizumab in Advanced Melanoma von MOSCHOS, Stergios J, SANDER, Cindy A, RICHMAN, Laura, MCKINNEY, Luann, LEININGER, Joel, TICE, David A, HAMMERSHAIMB, Luz, KIRKWOOD, John M, WENJUN WANG, REPPERT, Shelley L, DROGOWSKI, Laura M, JUKIC, Drazen M, RAO, Uma N. M, ATHANASSIOU, Charalambos, BUZOIANU, Manuela, MANDIC, Maja

Volltext

A randomized phase 2 study of etaracizumab, a monoclonal antibody against integrin α v β 3 , ± dacarbazine in patients with stage IV metastatic melanoma von Hersey, Peter, Sosman, Jeffrey, O'Day, Steven, Richards, Jon, Bedikian, Agop, Gonzalez, Rene, Sharfman, William, Weber, Robert, Logan, Theodore, Buzoianu, Manuela, Hammershaimb, Luz, Kirkwood, John M.

Volltext

Phase I Dose-Escalation Study of CAT-8015 (HA22), A CD22-Specific Targeted Immunotoxin, in Relapsed or Refractory Hairy Cell Leukemia von Kreitman, Robert J, Tallman, Martin S., Coutre, Steven, Robak, Tadeusz, Wilson, Wyndham H, Stetler-Stevenson, Maryalice, Noel, Pierre, FitzGerald, David J., Buzoianu, Manuela, Lechleider, Robert, Kaucic, Karen, Pastan, Ira

Volltext

Function Approximation Using Tensor Product Bernstein Polynomials-Neuro & Evolutionary Approaches von Buzoianu, Manuela, Oltean, Florin, Agapie, Alexandru

Volltext